Applied Therapeutics, Inc. — Director's Dealing 2022

Jan 28, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2022-01-25

Reporting Person: Shendelman Shoshana (Director, President and CEO, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-25	Employee Stock Option (Right to Buy)	$3.33	A	234616	Acquired	2032-01-25	Common Stock (234616)	Direct

Footnotes

F1: Consists of compensatory Options granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. The issuer determined to make this compensatory grant of Options to the Reporting Person in lieu of a cash bonus that otherwise would have been paid with respect to 2021. All of the shares subject to the compensatory Option vested immediately upon grant.